CGH
MLAB icon

Crossmark Global Holdings’s Mesa Laboratories MLAB Stock Holding History

Crossmark Global Holdings’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-965
Closed -$229K – 1420
2019
Q3 		$229K Buy
+965
New +$223K 0.01% 1199

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Crossmark Global Holdings's MLAB Position: Q4 2019 in Review

Crossmark Global Holdings sold out of Mesa Laboratories (MLAB) in Q4 2019, closing a stake of 965 shares — an estimated $229K sold.

Crossmark Global Holdings first reported a position in MLAB in Q3 2019 and held it in 1 quarter. The position peaked at $229K in Q3 2019. 151 funds tracked by Wall St. Rank hold MLAB as of Q4 2019.

  • Crossmark Global Holdings reported no remaining Mesa Laboratories position as of Q4 2019 after selling out during the quarter.
  • Crossmark Global Holdings sold 965 Mesa Laboratories shares in Q4 2019, an estimated $229K.
  • Crossmark Global Holdings first reported a position in Mesa Laboratories in Q3 2019 and held it in 1 quarter.
  • Crossmark Global Holdings's Mesa Laboratories position peaked at $229K in Q3 2019.
  • 151 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2019.

Based on Crossmark Global Holdings's 13F filing for Q4 2019, filed 6 Feb 2020.